Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy

Cytokines, Cellular and Molecular Therapy

Volumn 5, Issue 4, 1999, Pages 187-193

  Crawford, Jeffrey ^a,e   Tomita, Dianne K ^b   Mazanet, Rosemary ^b   Glaspy, John ^c   Ozer, Howard ^d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b AMGEN INC   (United States)

^c UCLA MEDICAL CENTER   (United States)

^d EMORY UNIVERSITY   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy; Filgrastim; Oral mucositis; Prospective trial; Small cell lung cancer

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEUTROPENIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FEMALE; FILGRASTIM; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOUTH MUCOSA; NECROSIS; NEUTROPENIA; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; STOMATITIS; SURVIVAL ANALYSIS;

EID: 0033506548     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Crawford J, Ozer H, Stoller R et al, Reduction by granulocyte colony-stimulating factor of fever and neutropenia by chemotherapy in patients with small-cell lung cancer. N Engl J Med (1991) 315: 164-70.
2. Verdi CJ, Cancer therapy and oral mucositis. An appraisal of drug prophylaxis. Drug Safety (1993) 9: 185-95.
3. Sonis S, Clark T, Prevention and management of oral mucositis induced by antineoplastic therapy. Oncology (1991) 5: 11-18.
4. Peterson DE, Sonis S, Oral complications of cancer chemotherapy: present status and future studies. Cancer Treat Rep (1982) 66: 1251-6.
5. Woo SB, Sonis ST, Sonis AL, The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients. Cancer (1990) 66: 2375-9.
6. Sonis AL, Sonis ST, Lieberman A, Oral complications of cancer chemotherapy in pediatric patients. J Pedodont (1979) 3: 122-8.
7. Peterson DE, Pretreatment strategies for infection prevention in chemotherapy patients. NCI Monogr (1990) 9: 61-71.
8. Beck SL, Prevention and management of oral complications in the cancer patient. In: Current Issues in Cancer Nursing Practice (ed SM Hubbard, PE Greene, MT Knobf) 27-38. Lippincott, Philadelphia, 1990.
9. Mahood DJ, Dose AM, Loprinzi CL et al, Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol (1991) 9: 449-52.
10. Cascinu S, Fedeli A, Fedeli SL et al, Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. Eur J Cancer B Oral Oncol (1994) 30B: 234-6.
11. Dumontet C, Sonnet A, Bastion Y et al, Revention of high-dose L-PAM-induced mucositis by cryotherapy. Bone Marrow Transplant (1994) 14: 492-4.
12. Wadleigh RG, Redman RS, Graham ML et al, Vitamin E in the treatment of chemotherapy-induced mucositis. Am J Med (1992) 92: 481-4.
13. Franzen L, Henriksson R, Littbrand B et al, Effect of sucralfate on mucositis before and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study. Acta Oncol (1995) 34: 219-23.
14. Makkonen TA, Bostrom P, Vilja P et al, Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study. J Radiat Oncol (1994) 30: 177-82.
15. Chi KW, Chen CH, Chan WK et al, Effect of granulocytemacrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol (1995) 13: 2620-8.
16. Nemunaitis J, Rosenfeld CS, Ash R et al, Phase-III randomized, double-blind, placebo-controlled trial of rhGM-CSF following allogeneic bone-marrow transplantation. Bone Marrow Transplant (1995) 15: 949-54.
17. Gordon B, Spadinger A, Hodges E et al. Effect of granulocyte-macrophage colony stimulating factor on oral mucositis after hematopoietic stem-cell transplantation. J Clin Oncol (1994) 12: 1917-22.
18. Keith JC, Albert L, Sonis ST et al, IL-11, a pleiotrophic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells (1994) 12: 79-89.
19. Sonis ST, Lindquist L, Van Vugt A et al. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor β3. Cancer Res (1994) 54: 1135-8.
20. Loprinzi CL, Ghosh C. Camoriano J et al. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. J Clin Oncol (1997) 15: 1235-8.
21. Bronchud MH, Howell A, Crowther D et al, The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer (1989) 60: 121-5.
22. Gabrilove JL, Jakubowski A, Scher H et al, Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium. N Engl J Med (1988) 318: 1414-22.
23. Morstyn G, Campbell L, Souza LM et al, Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy, Lancet (1988) i: 667-72.
24. Crawford J, Glaspy J, Vincent M et al. Effect of filgrastim (r-metHuG-CSF) on oral mucositis in patients with small cell lung cancer (SCLC) receiving chemotherapy (cyclophosphamide, doxorubicin and etoposide) (CAE). Proc Am Soc Clin Oncol (1994) 13: 1523a.
25. Lockhart PB, Sonis ST, Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy. Oral Surg (1979) 48: 21-8.
26. Dale DC, Bonilla MA, Davis MW et al, A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood (1993) 81: 2496-502.
27. Lieschke G, Ramenghi U, O'Connor MP et al, Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation. Br J Haematol (1992) 82: 589-95.
28. Lowes JR, Priddle JD, Jewell DP, Production of epithelial cell growth factors by lamina propria mononuclear cells. Gut (1992) 33: 39-43.
29. Sonis ST, Costa JW Jr, Evitts SM et al, Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. Oral Surg Oral Med Oral Pathol (1992) 74: 749-55.
30. Miller AB, Hoogstraten B, Staquet M, Winkle A, Reporting results of cancer treatment. Cancer (1981) 47: 207-14.